Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study. [electronic resource] by
- Muss, H B
- Case, L D
- Atkins, J N
- Bearden, J D
- Cooper, M R
- Cruz, J M
- Jackson, D V
- O'Rourke, M A
- Pavy, M D
- Powell, B L
Producer: 19940825
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 12
Availability: No items available.
|